Venous Thromboembolism Treatment Market by Size, Share, Forecast, & Trends Analysis
Meticulous
Research®—a
leading global market research company, published a research report
titled, ‘Venous Thromboembolism
Treatment Market by
Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent],
Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User
(Hospital, Ambulatory Care Center) – Global Forecast to 2030.’
Download
Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5745?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=18-04-2024
According
to this latest publication from Meticulous Research®,
the global venous thromboembolism treatment market is projected to reach $4.40
billion by 2030, at a CAGR of 7.2%. The high prevalence of venous
thromboembolism, rising incidence of cancer, growing prevalence of secondary
risk factors such as diabetes and obesity, increase in orthopedic surgical
procedures, and the rising demand for minimally invasive treatment procedures
are the key factors driving the growth of the venous thromboembolism treatment
market. Furthermore, the growing accessibility and affordability of treatment
options, advancements in VTE diagnosis and treatment methods, and the market
expansion in emerging economies are expected to create market growth
opportunities.
However,
instances of product failure and product recalls may restrain the market’s
growth. Additionally, lack of awareness about venous thromboembolism and
increasing awareness of probable side effects of compression garments are major
challenges for market growth.
Key
Players
The
key players profiled in the venous thromboembolism treatment market report are
ALN Implants chirurgicaux (ALN Surgical Implants) (France), AngioDynamics, Inc.
(U.S.), Argon Medical Devices, Inc. (U.S.), ArjoHuntleigh AB (Sweden), Boston
Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group
Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), DS MAREF Co., LTD
(South Korea), Enovis Corporation (U.S.), LifeTech Scientific Corporation
(China), Medtronic plc (Ireland), and Stryker Corporation (U.S.).
The
global venous thromboembolism treatment market is segmented by device
(thrombectomy devices, inferior vena cava filters {retrievable filters and
permanent filters}, stockings, compression pumps, and other devices &
accessories), application (deep vein thrombosis and pulmonary embolism), end
user (hospitals, ambulatory care centers, and other end users), and geography.
The study also evaluates industry competitors and analyzes the market at the
global and regional levels.
Based
on application, in 2023, the deep vein
thrombosis segment is expected to account for the largest share of the market.
The large market share of this segment is attributed to the increasing
geriatric population, rising cases of obesity, increasing cases of deep vein
thrombosis due to disease-causing lifestyle, excessive alcohol consumption, and
the growing awareness and early diagnosis of DVT. Obesity plays a significant
role in the development of venous stasis, increasing the susceptibility to DVT.
According to the World Health Organization (WHO), in 2021, the global
prevalence of obesity exceeded 1 million individuals, encompassing 340 million
adolescents, 650 million adults, and 39 million children. This number is
expected to increase by about 167 million people, including adults and
children, by 2025. Hence, the growing aging population and rising obesity rates
are anticipated to drive the demand for devices aimed at preventing deep vein
thrombosis during the forecast period
.Geographic
Review
This
research report analyzes major geographies and provides a comprehensive
analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy,
Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of
Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North
America is expected to account for the largest share of the venous
thromboembolism treatment market, followed by Europe.
Contact
Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment